These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 27135484)
21. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061 [TBL] [Abstract][Full Text] [Related]
22. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease. Szewczuk MR; Depew WT Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000 [TBL] [Abstract][Full Text] [Related]
23. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37. Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544 [TBL] [Abstract][Full Text] [Related]
24. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Tjabringa GS; Rabe KF; Hiemstra PS Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. Zaiou M; Nizet V; Gallo RL J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586 [TBL] [Abstract][Full Text] [Related]
26. CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features. Camacho FI; Muñoz C; Sánchez-Verde L; Sáez AI; Alcántara M; Rodríguez R Histopathology; 1999 Aug; 35(2):144-9. PubMed ID: 10460659 [TBL] [Abstract][Full Text] [Related]
27. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease. Tang R; Yang G; Zhang S; Wu C; Chen M Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103 [TBL] [Abstract][Full Text] [Related]
28. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Nuding S; Fellermann K; Wehkamp J; Stange EF Gut; 2007 Sep; 56(9):1240-7. PubMed ID: 17456510 [TBL] [Abstract][Full Text] [Related]
30. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200 [TBL] [Abstract][Full Text] [Related]
31. The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis. Zhang M; Liang W; Gong W; Yoshimura T; Chen K; Wang JM Crit Rev Immunol; 2019; 39(2):83-92. PubMed ID: 31679249 [TBL] [Abstract][Full Text] [Related]
32. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637 [TBL] [Abstract][Full Text] [Related]
33. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Dürr UH; Sudheendra US; Ramamoorthy A Biochim Biophys Acta; 2006 Sep; 1758(9):1408-25. PubMed ID: 16716248 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. Carvalho AT; Elia CC; de Souza HS; Elias PR; Pontes EL; Lukashok HP; de Freitas FC; Lapa e Silva JR J Clin Gastroenterol; 2003 Feb; 36(2):120-5. PubMed ID: 12544193 [TBL] [Abstract][Full Text] [Related]
35. The role of the multifunctional peptide LL-37 in host defense. Kai-Larsen Y; Agerberth B Front Biosci; 2008 May; 13():3760-7. PubMed ID: 18508470 [TBL] [Abstract][Full Text] [Related]
36. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease. Zhang W; Teng G; Wu T; Tian Y; Wang H Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078 [TBL] [Abstract][Full Text] [Related]
37. Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells. Gubatan J; Mehigan GA; Villegas F; Mitsuhashi S; Longhi MS; Malvar G; Csizmadia E; Robson S; Moss AC Inflamm Bowel Dis; 2020 May; 26(6):885-897. PubMed ID: 31955203 [TBL] [Abstract][Full Text] [Related]
38. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447 [TBL] [Abstract][Full Text] [Related]
39. Microbiota and mucosal defense in IBD: an update. Stange EF; Schroeder BO Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356 [No Abstract] [Full Text] [Related]
40. Expression of Programmed Death-Ligand 1 by Human Colonic CD90 Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV Front Immunol; 2018; 9():1125. PubMed ID: 29910803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]